ivabradine for junctional ectopic tachycardia in post congenital heart surgery
Clicks: 126
ID: 249305
2017
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
126 views
60 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #379 of 437 articles by views in renewable energy
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 437 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
We report two cases of malignant junctional ectopic tachycardia (JET), in infants following congenital heart surgery. After the failure of conventional therapy the arrhythmia was controlled by oral Ivabradine, a drug which is routinely used to lower heart rate in angina and heart failure in adult practice.
| Reference Key |
kumar2017indianivabradine
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Vivek Kumar;Gaurav Kumar;Sajan Joshi;Vipul Sharma |
| Journal | renewable energy |
| Year | 2017 |
| DOI |
10.1016/j.ihj.2017.09.007
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.